Ipsen: Summary

Ipsen

Biopharmaceutical, Healthcare, Specialty Pharmaceuticals, Therapeutics

Ipsen aims to improve health outcomes for patients by developing transformative medicines in areas of high unmet medical need.

Ipsen is a global biopharmaceutical company dedicated to improving patient lives through innovative medicines. The company focuses on three key therapeutic areas: Oncology, Rare Disease, and Neuroscience.

Focus on high unmet medical needs; Strong global presence and resources; Commitment to innovation and specialty care; Collaborative partnerships for R&D

Ipsen's services are most valuable in treating patients with rare diseases, cancer, and neurological disorders, where effective treatments are often lacking.

Established expertise in Oncology, Rare Disease, and Neuroscience; Strong track record in commercializing innovative therapies; Commitment to sustainability and patient-centered care

Ipsen's strengths include its focused therapeutic areas, a robust pipeline of innovative medicines, and a commitment to addressing high unmet medical needs.

Ipsen positions itself as a leader in specialty biopharmaceuticals, dedicated to innovation and improving patient care globally.

The target users include healthcare professionals, patients with rare diseases or cancer, and stakeholders in the biopharmaceutical industry.

Learn about our strategy

• biopharmaceuticals

• innovation

• patient care

• rare diseases

Focus. Together. For patients and society.

Professional, compassionate, innovative

Ipsen stands out in the biopharmaceutical market by prioritizing collaboration and innovation in its R&D efforts, specifically targeting rare diseases and complex conditions.

Ipsen's brand identity is centered around innovation, collaboration, and a commitment to patient outcomes, reflecting its mission to enhance lives through science.

1929-01-01

• Henri Beaufour